Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
96%
Continuous Glucose Monitoring
47%
Automated Insulin Delivery
32%
Closed-loop Control
29%
Hypoglycemia
28%
Continuous Glucose Monitor
25%
Glycemic Control
23%
Pregnant Women
21%
Type 2 Diabetes Mellitus (T2DM)
20%
Diabetes
19%
Closed-loop
17%
Insulin Pump
13%
Time in Range
13%
Hemoglobin A1c (HbA1c)
13%
Tubeless
13%
Insulin
12%
Blood Glucose
11%
Hybrid Closed Loop
10%
Omnipod
9%
Medicaid
9%
Older Adults
9%
Glycemic Outcomes
8%
Randomized Controlled Trial
8%
Multiple Daily Injections
8%
United States
8%
Women with Diabetes
8%
Sensor-augmented Pump
8%
Dexcom G6
8%
Gestational Diabetes Mellitus
7%
During Pregnancy
7%
Insulin Delivery
7%
Medicare
7%
Glycemic Targets
6%
Monitoring Value
6%
Patients with Diabetes
6%
Diabetes Technology
6%
Continuous Subcutaneous Insulin Infusion
6%
Plasma Glucose
5%
Insulin Dose
5%
Children with Type 1 Diabetes
5%
Closed-loop System
5%
Artificial Pancreas
5%
Multicenter Trial
5%
Hotels
5%
Bolus
5%
Sensor-augmented Pump Therapy
5%
Coverage Criteria
5%
Psychosocial Outcomes
5%
Adolescents with Type 1 Diabetes
5%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
67%
Diabetes
45%
Insulin Pump
21%
Hemoglobin A1c
19%
Hypoglycemia
17%
Glycemic
16%
Glycemic Control
16%
Arm
12%
Maturity Onset Diabetes of the Young
12%
Gestational Diabetes
10%
Adolescence
8%
Diabetes Mellitus
8%
Medicare
7%
Insulin Infusion
7%
Adverse Event
6%
Randomized Controlled Trial
5%
Clinical Trial
5%
Antidiabetic Agent
5%
Blood Glucose Monitoring
5%